Table of Contents

March 11, 2004
Volume 47, Issue 6
Pages 1303-1594

About the Cover: Molecular modeling of overlayed trisubstituted acridine derivatives (mauve and green) complexed with G-quadruplex DNA (Harrison, R. J.; et al. J. Med. Chem. 2003, 46, 4463-4476).

Perspective

Selective Optimization of Side Activities:  Another Way for Drug Discovery

pp 1303–1314
Publication Date (Web): February 13, 2004 (Perspective)
DOI: 10.1021/jm030480f

Letters

A Non-Peptide NK1 Receptor Agonist Showing Subpicomolar Affinity

pp 1315–1318
Publication Date (Web): February 11, 2004 (Letter)
DOI: 10.1021/jm034219a

Evaluation of Potent and Selective Small-Molecule Antagonists for the CXCR2 Chemokine Receptor

pp 1319–1321
Publication Date (Web): February 11, 2004 (Letter)
DOI: 10.1021/jm034248l

Synthesis of a Potent Transition-State Inhibitor of 5‘-Deoxy-5‘-methylthioadenosine Phosphorylase

pp 1322–1324
Publication Date (Web): February 17, 2004 (Letter)
DOI: 10.1021/jm030455+

Crystal Structures of Staphylococcus aureus Methionine Aminopeptidase Complexed with Keto Heterocycle and Aminoketone Inhibitors Reveal the Formation of a Tetrahedral Intermediate

pp 1325–1328
Publication Date (Web): February 07, 2004 (Letter)
DOI: 10.1021/jm034188j

Articles

Studies on Pyrrolopyrimidines as Selective Inhibitors of Multidrug-Resistance- Associated Protein in Multidrug Resistance

pp 1329–1338
Publication Date (Web): February 07, 2004 (Article)
DOI: 10.1021/jm031011g

Design and Synthesis of New Templates Derived from Pyrrolopyrimidine as Selective Multidrug-Resistance-Associated Protein Inhibitors in Multidrug Resistance

pp 1339–1350
Publication Date (Web): February 07, 2004 (Article)
DOI: 10.1021/jm0310129

3-(4-Aroyl-1-methyl-1H-pyrrol-2-yl)-N-hydroxy-2-propenamides as a New Class of Synthetic Histone Deacetylase Inhibitors. 3. Discovery of Novel Lead Compounds through Structure-Based Drug Design and Docking Studies,

pp 1351–1359
Publication Date (Web): February 10, 2004 (Article)
DOI: 10.1021/jm031036f

A Computational Model for Anthracycline Binding to DNA:  Tuning Groove-Binding Intercalators for Specific Sequences

pp 1360–1374
Publication Date (Web): February 14, 2004 (Article)
DOI: 10.1021/jm030529h

Structure-Based Optimization of Novel Azepane Derivatives as PKB Inhibitors

pp 1375–1390
Publication Date (Web): February 17, 2004 (Article)
DOI: 10.1021/jm0310479

New Analogues of Amonafide and Elinafide, Containing Aromatic Heterocycles:  Synthesis, Antitumor Activity, Molecular Modeling, and DNA Binding Properties

pp 1391–1399
Publication Date (Web): February 07, 2004 (Article)
DOI: 10.1021/jm0308850

Identification of Opioid Ligands Possessing Mixed μ Agonist/δ Antagonist Activity among Pyridomorphinans Derived from Naloxone, Oxymorphone, and Hydropmorphone

pp 1400–1412
Publication Date (Web): February 10, 2004 (Article)
DOI: 10.1021/jm030311v

Synthesis and Evaluation of Dihydropyrroloquinolines That Selectively Antagonize P-Glycoprotein

pp 1413–1422
Publication Date (Web): February 10, 2004 (Article)
DOI: 10.1021/jm0303204

Orally Active Antimalarials: Hydrolytically Stable Derivatives of 10-Trifluoromethyl Anhydrodihydroartemisinin

pp 1423–1433
Publication Date (Web): February 11, 2004 (Article)
DOI: 10.1021/jm030947m

Design, Synthesis, and Biological Evaluation of New 8-Heterocyclic Xanthine Derivatives as Highly Potent and Selective Human A2B Adenosine Receptor Antagonists

pp 1434–1447
Publication Date (Web): February 17, 2004 (Article)
DOI: 10.1021/jm0309654

Design, Synthesis, and Evaluation of Novel Thienopyrrolizinones as Antitubulin Agents

pp 1448–1464
Publication Date (Web): February 13, 2004 (Article)
DOI: 10.1021/jm030961z

Comparative in Vivo Stability of Copper-64-Labeled Cross-Bridged and Conventional Tetraazamacrocyclic Complexes

pp 1465–1474
Publication Date (Web): February 12, 2004 (Article)
DOI: 10.1021/jm030383m

New 2,4-Diamino-5-(2‘,5‘-substituted benzyl)pyrimidines as Potential Drugs against Opportunistic Infections of AIDS and Other Immune Disorders. Synthesis and Species-Dependent Antifolate Activity

pp 1475–1486
Publication Date (Web): February 05, 2004 (Article)
DOI: 10.1021/jm030438k

New Antibacterial Agents Derived from the DNA Gyrase Inhibitor Cyclothialidine

pp 1487–1513
Publication Date (Web): February 05, 2004 (Article)
DOI: 10.1021/jm0310232

De Novo Design, Synthesis, and Pharmacology of α-Melanocyte Stimulating Hormone Analogues Derived from Somatostatin by a Hybrid Approach

pp 1514–1526
Publication Date (Web): February 07, 2004 (Article)
DOI: 10.1021/jm030452x

Anticonvulsant Activity of Phenylmethylenehydantoins:  A Structure−Activity Relationship Study

pp 1527–1535
Publication Date (Web): February 13, 2004 (Article)
DOI: 10.1021/jm030450c

First Reported Nonpeptide AT1 Receptor Agonist (L-162,313) Acts as an AT2 Receptor Agonist in Vivo

pp 1536–1546
Publication Date (Web): February 14, 2004 (Article)
DOI: 10.1021/jm031031i

3-(4-Phenoxyphenyl)pyrazoles:  A Novel Class of Sodium Channel Blockers

pp 1547–1552
Publication Date (Web): February 10, 2004 (Article)
DOI: 10.1021/jm030498q

Design, Synthesis, and Evaluation of Aza-Peptide Epoxides as Selective and Potent Inhibitors of Caspases-1, -3, -6, and -8

pp 1553–1574
Publication Date (Web): February 07, 2004 (Article)
DOI: 10.1021/jm0305016

Structure−Activity Relationships of Potent, Selective Inhibitors of Neuronal Nitric Oxide Synthase Based on the 6-Phenyl-2-aminopyridine Structure

pp 1575–1586
Publication Date (Web): February 04, 2004 (Article)
DOI: 10.1021/jm030519g

Brief Articles

Arecoline Tripeptide Inhibitors of Proteasome

pp 1587–1590
Publication Date (Web): February 10, 2004 (Brief Article)
DOI: 10.1021/jm0309102

New Steroidal Dimers with Antifungal and Antiproliferative Activity

pp 1591–1594
Publication Date (Web): February 11, 2004 (Brief Article)
DOI: 10.1021/jm030376y